Your testosterone levels start to decline around your thirties, which may give way to debilitating symptoms like fatigue, weight gain and even erectile dysfunction
5Amino1MQ (5Amino1Methylquinolinium) is a novel small molecule derived from quinolinium salts that has been studied for its ability to inhibit NNMT (Nicotinamide NMethyltransferase), an enzyme involved in metabolic dysfunction, obesity, and cellular aging
It works by modulating the GABAergic system in the brain, which can promote relaxation, reduce symptoms of anxiety, and improve sleep quality
Research into 5-Amino-1MQ has been conducted primarily in preclinical (animal and cellular) models, and it has not been approved by the MHRA, NICE, or any major regulatory authority for human therapeutic use
The same applies to understanding its testing profile: complete information is always better than partial reassurance